Alexion Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides (NASDAQ:ALXN) | Seeking Alpha
Alexion Pharmaceuticals, Inc. 2017 Q3 - Results - Earnings Call Slides (NASDAQ:ALXN) | Seeking Alpha
Alexion records $165M restructuring charge in 3Q; revenues up | Hartford Business Journal
Alexion Exits New Haven For Boston, Agrees To Repay Millions In State Aid – Hartford Courant
Alexion might be a restructuring play, but price is key | Evaluate
Alexion Pharmaceuticals Will Move Headquarters To Boston | Connecticut Public
AstraZeneca's Alexion hopes to extend dominance in PNH
AlexionPartners | Global Management Consulting Firm
Alexion Partners (@AlexionPartners) / Twitter
Covid vaccine maker AstraZeneca says 2021 profit dives | Mossel Bay Advertiser
Is Alexion's Boston Move A Smoke Screen? – Hartford Courant
Activist Investor Urges Alexion to Sell Itself or Else | BioSpace
Freshfields and Wachtell Guide AstraZeneca-Alexion Merger
Alexion plots hundreds of layoffs, HQ move in sweeping corporate revamp | Fierce Pharma
Alexion to Acquire Wilson Therapeutics | Business Wire
Lessons to be learned from Alexion - ConvergenceRI
Alexion to Restructure Operations, to Lower Headcount by 20%
Drug maker Alexion to close R.I. plant
Alexion Pharmaceuticals Inc. plans to fire 20% of its global workforce as part of a restructuring effort
Alexion closing RI manufacturing facility, 250 losing jobs
Alexion Pharmaceuticals loses general counsel, government affairs head amid Boston headquarters relocation - Boston Business Journal
Alexion Pharmaceuticals (ALXN) Slashes 20% of Its Workforce So It Could Boost Profits - TheStreet
JPM: Alexion gives an updated look at what AstraZeneca's getting for $39B | Fierce Pharma
